Back

Effect on ventricular arrhythmias of sacubitril-valsartan in continuous home monitoring implantable cardiac defibrillator patients

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Acute heart failure (AHF) AHF - Drug treatment ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Carlos De Diego

Vinalop University Hospital, Alicante (Spain)

17 More presentations in this session

Presentation thumbnail
Doctor T. Yamada (Osaka, JP)
Abstract Slides
Presentation thumbnail
Doctor C. Pirlet (Liege, BE)
Abstract Slides
Presentation thumbnail
Doctor K. Krychtiuk (Vienna, AT)
Abstract Slides
Presentation thumbnail
Doctor J. Benes (Prague, CZ)
Abstract
Presentation thumbnail
Professor G. Gislason (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Poster session 4 - Acute heart failure (AHF)

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Antiarrhythmic effect of Sacubitril-Valsartan: effects beyond reverse cardiac remodelling?
29 June 2021
thumbnail
Congress Presentation
Real-world off-label Sacubitril/Valsartan dosing and clinical outcomes in patients with heart failure and end-stage kidney disease
31 August 2026
thumbnail
ESC Journals
Right ventricular strain as prognostic marker in patients with heart failure receiving sacubitril/valsartan: a sub-analysis of DISCOVER-ARNI, a multicenter Italian study
29 January 2025
thumbnail
Congress Presentation
Systemic H-FABP, hs-cTnT, hs-CRP and Monocyte-to-Lymphocyte ratio were significantly reduced by sacubitril/valsartan in doxorubicin-treated preclinical models through NLRP3-mTOR-AKT pathways
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources